AU7089194A - Fucosylated glycosides as inhibitors of bacterial adherence - Google Patents

Fucosylated glycosides as inhibitors of bacterial adherence

Info

Publication number
AU7089194A
AU7089194A AU70891/94A AU7089194A AU7089194A AU 7089194 A AU7089194 A AU 7089194A AU 70891/94 A AU70891/94 A AU 70891/94A AU 7089194 A AU7089194 A AU 7089194A AU 7089194 A AU7089194 A AU 7089194A
Authority
AU
Australia
Prior art keywords
fucα1
alkyl
spacer
group
2galβ1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70891/94A
Other languages
English (en)
Inventor
Karin Ingeborg Eklind
Hans Roland Lonn
Anna-Karin Ulla Edit Tiden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU7089194A publication Critical patent/AU7089194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU70891/94A 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence Abandoned AU7089194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK761/93 1993-06-25
DK93761A DK76193D0 (da) 1993-06-25 1993-06-25 Kulhydratderivater
PCT/SE1994/000604 WO1995000527A1 (fr) 1993-06-25 1994-06-17 Glycosides fucosyles inhibiteurs de l'adhesion bacterienne

Publications (1)

Publication Number Publication Date
AU7089194A true AU7089194A (en) 1995-01-17

Family

ID=8097261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70891/94A Abandoned AU7089194A (en) 1993-06-25 1994-06-17 Fucosylated glycosides as inhibitors of bacterial adherence

Country Status (9)

Country Link
EP (1) EP0706528A1 (fr)
JP (1) JPH08512026A (fr)
AU (1) AU7089194A (fr)
CA (1) CA2164961A1 (fr)
DK (1) DK76193D0 (fr)
IL (1) IL110074A0 (fr)
IS (1) IS4181A (fr)
LT (1) LT3446B (fr)
WO (1) WO1995000527A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
JPH1160590A (ja) * 1997-08-22 1999-03-02 Yakult Honsha Co Ltd オリゴフコース誘導体又はオリゴラムノース誘導体及びその製造法
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
CA2618638C (fr) * 2005-08-09 2014-03-11 Glycomimetics, Inc. Inhibiteurs glycomimetiques de lectine pa-il ou de lectine pa-iil, ou lectines pa-il et pa-iil provenant de pseudomonas
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
EP3296310A1 (fr) 2011-12-22 2018-03-21 GlycoMimetics, Inc. Composés antagonistes d' e-sélectine, compositions et procédés d' utilisation
EP2692740A1 (fr) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Compositions de glycane, leurs procédés de préparation et leurs utilisations en tant que médicament
HUE038423T2 (hu) 2012-12-07 2018-10-29 Glycomimetics Inc E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
CN105101972A (zh) * 2013-01-31 2015-11-25 先锋国际良种公司 用于改善植物生长和产量的合成型脂质几丁寡糖
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2016089872A1 (fr) 2014-12-03 2016-06-09 Glycomimetics, Inc. Inhibiteurs hétérobifonctionnels des e-sélectines et des récepteurs aux chimiokines cxcr4
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
WO2017151708A1 (fr) 2016-03-02 2017-09-08 Glycomimetics, Inc. Méthodes pour le traitement et/ou à la prévention de maladies cardiovasculaires par inhibition de la sélectine e
WO2018031445A1 (fr) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combinaison d'inhibiteurs des points de contrôle des lymphocytes t avec des inhibiteurs de e-sélectine ou de cxcr4, ou avec des inhibiteurs hétérobifonctionnels de e-sélectine et de cxcr4
WO2018068010A1 (fr) 2016-10-07 2018-04-12 Glycomimetics, Inc. Antagonistes de e-sélectine multimériques très puissants
EP3596096A1 (fr) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Dérivés de galactopyranosyle-cyclohexyle utilisés en tant qu'antagonistes d'e-sélectine
WO2019108750A1 (fr) 2017-11-30 2019-06-06 Glycomimetics, Inc. Méthodes de mobilisation de lymphocytes infiltrant la moelle et leurs utilisations
JP7304863B2 (ja) 2017-12-29 2023-07-07 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンおよびガレクチン－３のヘテロ二機能性阻害剤
CA3091454A1 (fr) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methodes de traitement de la leucemie aigue myeloide et d'etats pathologiques associes
CN112638944A (zh) 2018-08-23 2021-04-09 西进公司 抗tigit抗体
KR20210110645A (ko) 2018-12-27 2021-09-08 글리코미메틱스, 인크. 갈렉틴-3 억제 c-글리코사이드
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
DE3220427A1 (de) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg Ss-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
EP0348143A3 (fr) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Dérivés de bismuth de phosphates et sulphates de saccharides

Also Published As

Publication number Publication date
LTIP1978A (en) 1995-01-31
EP0706528A1 (fr) 1996-04-17
IS4181A (is) 1994-12-26
LT3446B (en) 1995-10-25
DK76193D0 (da) 1993-06-25
JPH08512026A (ja) 1996-12-17
CA2164961A1 (fr) 1995-01-05
IL110074A0 (en) 1994-10-07
WO1995000527A1 (fr) 1995-01-05

Similar Documents

Publication Publication Date Title
AU7089194A (en) Fucosylated glycosides as inhibitors of bacterial adherence
IL77603A (en) Pharmaceutical preparations containing saccharide with antiviral activity and 2-modified hydrocarbylsulfonyl (new ethylsaccharide
US11191822B2 (en) Pneumococcal polysaccharide-protein conjugate composition
AU705012B2 (en) Treatment of traveller's diarrhea
EP1575619A1 (fr) Oligosaccharides et conjugues pour le traitement d'infections par bacterie pseudomonale
US20040219158A1 (en) Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
EP1642132B1 (fr) Glycoconjuges et leur utilisation comme vaccins potentiels contre une infection provoquee par shigella flexneri
EP0126043A1 (fr) Dérivés de carbohydrates et compositions à usage thérapeutique ou diagnostique
US5962423A (en) Treatment of bacterial dysentery
AU713668B2 (en) Treatment of traveller's diarrhea
US6238668B1 (en) Colon cancer KH-1 and N3 antigens
US20240024489A1 (en) Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof
WO2015181834A2 (fr) Nouveau vaccin conjugué méningococcique semi-synthétique
JPH09509931A (ja) 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法
DE10138935B4 (de) Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus
WO2000056343A1 (fr) Structures glucidiques de n-acetyl lactosamine fucosyle sialyle permettant d'inhiber l'adhesion bacterienne
EP3269385A1 (fr) Composition de conjugués de polysaccharide-protéine pneumococcique
EP4245764A1 (fr) Nouveaux dérivés glucidiques comme mimétiques des antigènes des groupes sanguins a et b
JP3369555B2 (ja) 薬剤および他の作用剤を標的へ向かわせるレセプター複合体
US5891860A (en) Treatment of traveller's diarrhea
KR20240037237A (ko) Tlr4 수용체의 신규 합성 효능제
CA2434685A1 (fr) Nouvelle approche d'elaboration de glycopeptides a base de polysaccharide o-specifique du serotype 2a de shigella flexneri
Jiao An anti-Clostridium difficile vaccine: chemical synthesis of the pentasaccharide repeating unit of polysaccharide PS-I
Weingart et al. Binding of Toxoplasma gondii Glycosylphosphatidylinositols to Galectin-3 Is Required for Their Recognition by Macrophages